RCM — R1 RCM Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
- $6.04bn
- $8.09bn
- $2.25bn
Annual cashflow statement for R1 RCM, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K/A | 10-K/A | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 12 | 117 | 87.3 | -63.3 | 3.3 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 53.4 | -1 | 85.9 | 122 | 146 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.1 | -122 | -17.5 | -234 | -72.5 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 114 | 61.8 | 257 | -9.9 | 340 |
| Capital Expenditures | -61 | -49.3 | -51.7 | -102 | -103 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -67.7 | -280 | -848 | -0.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -61 | -117 | -332 | -950 | -103 |
| Financing Cash Flow Items | -11 | -76.9 | -35.7 | -33.4 | -21.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -25.3 | 138 | 31.4 | 943 | -174 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 27.4 | 82.3 | -44.7 | -20 | 63.5 |